logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Taris Biomedical LLC


USPTO Granted Patents = 61

% Expired Patents = 9.8



Forward Citations = 292

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Heejin Lee (45 out of 55 patents)

silverMedal Karen Danielle Daniel (22 out of 26 patents)

bronzeMedal Cheryl Larrivee-Elkins (17 out of 23 patents)

4.  Dennis Giesing (17 out of 23 patents)

5.  Michael John Cima (10 out of 105 patents)

6.  Matthew Sansone (8 out of 9 patents)

7.  Burleigh M Hutchins, Iii (6 out of 12 patents)

8.  Hong Linh Ho Duc (6 out of 9 patents)

9.  Grace Kim (4 out of 7 patents)

10.  Paul C DiCesare (3 out of 77 patents)

11.  Andrew Barnes (3 out of 7 patents)

12.  Eric Britschock (3 out of 3 patents)

13.  David Sutton (3 out of 3 patents)

14.  Jeffrey P Radziunas (3 out of 60 patents)

15.  Jim Boyko (3 out of 3 patents)


Core Competencies:
Bladder Cancer
Intravesical Device
Drug Delivery
Solid Drug Tablets
Elastic Polymer-Drug Matrix
Multi-Lumen Devices
Trospium Treatment
Implantable Devices
Controlled Drug Release
Urological Devices
Genitourinary Sites
Tumor Metastasis

61 patents:

1. 12582599 - Methods for treatment of bladder cancer with gemcitabine (2026-03-24),
2. 12576253 - Drug delivery device with intravesical tolerability (2026-03-17),
3. 12447241 - Multi-unit drug delivery devices and methods (2025-10-21),
4. 12409304 - Drug delivery devices with drug-permeable component and methods (2025-09-09),
5. 12403086 - Solid drug tablets for implantable drug delivery devices (2025-09-02),
6. 12263244 - Intravesical device for controlled drug delivery (2025-04-01),
7. 12239807 - Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems (2025-03-04),
8. 12214148 - Multi-lumen drug delivery devices and methods (2025-02-04),
9. 12133913 - Methods of treating overactive bladder using trospium (2024-11-05),
10. 12090292 - Drug delivery devices and methods for drug delivery (2024-09-17),
11. 12059428 - Methods of treating tumor metastasis (2024-08-13),
12. 12029749 - Methods of treatment and maintenance therapy for bladder cancer using gemcitabine (2024-07-09),
13. 11992583 - Drug delivery devices and methods (2024-05-28),
14. 11904123 - Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems (2024-02-20),
15. 11890439 - Drug delivery device with intravesical tolerability (2024-02-06),
TARIS Biomedical LLC is a leading biopharmaceutical company focused on developing innovative therapies to treat serious diseases. They specialize in the design and delivery of targeted therapies for urological and gastrointestinal disorders using their proprietary drug delivery technology. With a mission to improve the lives of patients, TARIS Biomedical combines expertise in drug delivery, biomaterials, and clinical development to advance therapeutic solutions. Visit their website for more information and updates on their groundbreaking research and product development.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Taris Biomedical LLC
61 Patents

#14 in Lexington, MA

#335 in Massachusetts

#5,908 in US

#11,907 in the World

Lexington, MA (US)
Lexington, MA, United States of America

Taris Biomedical LLC

Forward Citations = 292

29 inventors:

goldMedal Heejin Lee (45 out of 55 patents)

silverMedal Karen Danielle Daniel (22 out of 26 patents)

bronzeMedal Cheryl Larrivee-Elkins (17 out of 23 patents)

4.  Dennis Giesing (17 out of 23 patents)

5.  Michael John Cima (10 out of 105 patents)

Please report any incorrect information to [email protected]
Loading…